Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920264 · ClinicalTrials.gov registry record · Phase 1
Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial
A Phase 1 study of This Study Will Evaluate Whether TXA Reduces Pain, sponsored by St. Louis Joint Replacement Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT06920264: Completed Phase 1 study of This Study Will Evaluate Whether TXA Reduces Pain, sponsored by St. Louis Joint Replacement Institute.
NCT06920264 is a Phase 1 study of This Study Will Evaluate Whether TXA Reduces Pain that has completed, run by St. Louis Joint Replacement Institute. The registered enrollment target is 165 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06920264, a Phase 1 study of This Study Will Evaluate Whether TXA Reduces Pain, has completed, sponsored by St. Louis Joint Replacement Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
To our knowledge, no studies examining the use of TXA after shoulder arthroscopy in an outpatient setting have been published. This study will evaluate whether TXA reduces pain as measured by opioid consumption and a visual analog scale for pain (VAS) for the first 72 hours after surgery. Secondary outcomes will examine whether patients were satisfied overall with their postoperative pain control, whether the time to first opioid use is increased, and whether the surgeon perceives improved surgical visualization in patients who received TXA. We will also examine the number of times pump pressure was increased during the procedure to improve visualization.
Conditions Studied
Interventions
- OTHER placebo
- DRUG Tranexamic acid
Study Locations (1)
Missouri
- SSM Health- DePaul - Bridgeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2024-09-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06920264
The ClinicalTrials.gov registry entry for NCT06920264 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis Joint Replacement Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with This Study Will Evaluate Whether TXA Reduces Pain appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT06920264 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06920264 about?
NCT06920264 is a clinical study titled "Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial". To our knowledge, no studies examining the use of TXA after shoulder arthroscopy in an outpatient setting have been published. This study will evaluate whether TXA reduces pain as measured by opioid consumption and a visual analog scale for pain (VAS) for the first 72 hours after surgery. Secondary ...
What is the current status of trial NCT06920264?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 165 participants. The study started on 2021-07-01. Estimated completion is 2024-09-30.
What conditions does trial NCT06920264 study?
This clinical trial studies the following conditions: This Study Will Evaluate Whether TXA Reduces Pain.
What interventions are being tested in trial NCT06920264?
The interventions under investigation include: placebo (OTHER), Tranexamic acid (DRUG).
Who is sponsoring clinical trial NCT06920264?
This trial is sponsored by St. Louis Joint Replacement Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06920264 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.